Oral Biologics & Biosimilar Drugs Global Market Report 2023 – By Therapy (Lymphocyte Modulators, Interleukin Inhibitors, Tumor Necrosis Factor-Alpha Inhibitors), By Disease (Asthma, Crohn'S Disease, Carcinoma, Arthritis, Diabetes, Multiple Myeloma, Enterocolitis, Multiple Sclerosis, Sarcoma, Psoriasis and Others), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Other Molecule Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2023-2032

Dental Services are diagnostic, preventive, and corrective treatments related to teeth and gums. These services are used to maintain good oral health. Dental services include any professional services provided by individuals who are duly licensed to practice dentistry or dental therapy under the laws of this state. The main types of dental services are general dentistry, oral surgery, orthodontics and prosthodontics, and other dental services. Any surgical treatment performed by dental specialist in or around the mouth and jaw is referred to as oral surgery. The different procedure types include cosmetic dentistry, and non-cosmetic dentistry which are available in various expenditure types such as public and private. The services are used by male and female. The global dental services market is segmented - 1) By Type: General Dentistry, Oral Surgery, Orthodontics And Prosthodontics, Other Dental Services 2) By Type of Procedure: Cosmetic Dentistry, Non-cosmetic Dentistry 3) By End User Gender: Male, Female 4) By Type of Expenditure: Public, Private Subsegments Covered: Restorative Services, Preventive Services, Diagnostic Services, Endodontic Surgery, Oral And Maxillofacial Surgery (Excluding Implants), Dental Implantation Services, Orthodontics, Prosthodontics The global dental services market grew from $471.19 billion in 2022 to $507.75 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The dental services market is expected to grow to $656.55 billion in 2027 at a CAGR of 6.6%. The dental services market is expected to benefit from an increase in demand for dental procedures, with rising in awareness regarding medical conditions. People are increasingly referring to medical websites and journals on the internet for information on dental issues. They are then searching for clinics, doctors, and various treatments being offered by independent dentists, clinics or dental hospitals. Many blogs such as deardoctor.com, dentalbuzz.com, and brightnow.com are publishing articles on dental health and answering individual queries, driving the demand for dental services. Major companies in the dental services market include ENVISTA HOLDINGS CORPORATION, Integrated Dental Holdings (IDH), NHS England, Henry Schein, Inc., Abano Healthcare Group Limited, Aspen Dental Management, Inc., Q & M Dental Group (Singapore) Limited and Healthway Medical Corp Ltd. Price limits by regulatory bodies on certain dental services affected the market in the historic period and will continue affecting the market in the forecast period. These price caps are placed to make healthcare services more accessible and affordable to patients, but negatively impact the revenues of dental services companies. Dental services companies, therefore, have to deal with pricing pressure while maintaining the quality of the services provided. Also, the rising cost of dental devices and other equipment continues to add to the overall cost burden. Dental waste disposable also increases the overall expenditures of dental service practices. These factors are expected to limit the growth of the market going forward. The dental services industry is experiencing a change in its delivery model through dental service organizations or dental support organizations (DSOs) giving rise to more corporate or group practices. DSOs are independent business support centres that contract with dental services providers and provide critical business management and support to dental practices, including non-clinical operations. The DSOs are facilitating more in-house treatments such as orthodontics, endodontic and oral maxillofacial surgery instead of being referred to a separate specialist. Group practices provide improved funding for infrastructure, equipment and expenses associated with iring specialists. According to the 2020 survey of U.S. Dental School Seniors by American Dental Education Association, an American non-profit organization, almost a third of population that planned to go for private practice after graduation were planning to join a DSO. Additionally, according to the American Dental Association, an American association of dental professionals, the DSOs were predicted to have a growth of about 100% between 2018 and 2025 and the market share was expected to triple by 2035. North America was the largest region in the dental services market in 2022. Asia-Pacific was the second largest region in the dental services market. The regions covered in the dental services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the dental services market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The dental services market includes revenues earned by entities by providing cosmetic dental services, endodontic procedures, pediatric dental services, periodontal services, and diagnostic dental services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The dental services market research report is one of a series of new reports from The Business Research Company that provides dental services market statistics, including dental services industry global market size, regional shares, competitors with a dental services market share, detailed dental services market segments, market trends and opportunities, and any further data you may need to thrive in the dental services industry. This dental services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dental practice management refer to software solutions and tools used to operate dental, medical, and healthcare practices in an efficient and organized method. The purpose of the software is to help in improving communication between dentists, their staff, and patients by increasing the legibility of clinical notes and documents and reducing clinical mistakes in the process. The main deployment modes of dental practice management include web, cloud, and on-premises based. Web-based dental practice management refers to web-based dental software that provides clinical operation support, dental EHR, and administrative support to independent and DSO practices over the internet with a web browser. Patient communication software, invoice/billing software, payment processing software, and insurance management are the applications of dental practice management. This software is used by dental clinics, hospitals, and others. The global dental practice management market is segmented - 1) By Deployment Mode: Web-Based, Cloud-Based, On-Premise 2) By Application: Patient Communication Software, Invoice/Billing Software, Payment Processing Software, Insurance Management, Other Applications 3) By End User: Dental Clinics, Hospitals, Other End Users The global dental practice management market size will grow from $1.6 billion in 2022 to $1.77 billion in 2023 at a compound annual growth rate (CAGR) of 11.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the dental practice management is expected to grow to $2.77 billion in 2027 at a CAGR of 11.8%. Growing dental visits is significantly driving the growth of the dental practice management market. The increasing prevalence of oral diseases, shifting consumer awareness towards oral care, and growing availability of dental practitioners are contributing to rapid growth in dental visits across the globe. The rapid growth in dental visits is expected to boost demand for dental practice management, as the majority of practitioners are focusing on adopting advanced web-based software and tools to streamline operations. For instance, according to a study published in the International Journal of Environmental Research & Public Health, the number of dental appointments by existing patients increased by 84% between 2019 and 2020. Therefore, increasing dental visits is expected to boost demand for dental practice management during the forecast period. Major players in the dental practice management market are Henry Schein Inc., Patterson Companies Inc., NextGen Healthcare Information Systems LLC, ACE Dental, Carestream Dental, Curve Dental Inc., Datacon Dental Systems Inc., DentiMax, ABELDent, MOGO Inc., Open Dental Software, Practice-Web Inc., Allscripts Healthcare Solutions, Athenahealth, Compudent Systems Inc., Dovetail Dental Software, Practice Web, and NXGN Management LLC. Technological advancement is a key trend gaining popularity in the dental practice management market. Major dental practice management companies are focused on developing new technological solutions to meet end-customer demands and strengthen their position. These companies are implementing next-gen technologies such as cloud-based dental software, digital impressions, 3D printing, digital X-ray, and others to enhance the clinical experience and client satisfaction. For instance, In October 2020, a US-based medication company, Carestream Dental LLC, introduced the exocad smile creator in Carestream Dental CS Imaging and Scanflow Software, allowing dental practitioners to customize a patient's smile. This facial analysis helps users in designing the optimal smile for the patient's unique anatomy. In August 2022, Planet DDS, a US-based provider of cloud-based dental software, acquired QSIDental from NextGen Healthcare, Inc., for an undisclosed amount. This QSIDental acquisition will include QSIDental Web®, reinforcing Planet DDS's commitment to cloud-based solutions for dental practices to navigate and discover new opportunities during unusual times in the industry. QSI Dental is a US-based practice management and EMR system for dentists. North America was the largest region in the dental practice management market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dental practice management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the dental practice management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The dental practice management market includes revenues earned by entities by providing services such as scheduling appointments with patients, maintain clinical documentation, handling patient charts and compile notes, billing patients and insurance companies, staff time scheduling and tracking, process insurance claims. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The dental practice management market research report is one of a series of new reports from The Business Research Company that provides dental practice management market statistics, including dental practice management industry global market size, regional shares, competitors with a dental practice management market share, detailed dental practice management market segments, market trends and opportunities, and any further data you may need to thrive in the dental practice management industry. This dental practice management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Dental X-ray equipment is used to capture images of the interior of teeth and gums and helps in identifying dental problems such as decaying teeth, cavities, and others. The main types of dental X-ray equipment are extraoral X-ray systems, intraoral X-ray systems, and hybrid X-ray systems. Extraoral X-rays are the type of X-ray in which the X-ray film is kept outside the mouth to capture the images. The technologies involved in dental X-ray equipment are digital and analog. These are used in cosmetics, medical, and forensics applications. The global dental X-ray equipment market is segmented - 1) By Type: Extraoral X-Ray Systems, Intraoral X-Ray Systems, Hybrid X-Ray Systems 2) By Technology: Digital, Analog 3) By Application: Cosmetics, Medical, Forensics The global dental X-ray equipment market size grew from $2.2 billion in 2022 to $2.55 billion in 2023 at a compound annual growth rate (CAGR) of 15.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global dental X-ray equipment is expected to grow from $4.4 billion in 2027 at a CAGR of 14.6%. Increasing cases of oral disorders are a major factor contributing to the demand for the dental X-ray equipment market. Dental X-rays or panoramic image is a vital part of dental care and help the dentist to access oral health including hidden dental structures, bone loss, malignant or benign masses, and cavities. According to the World Health Organization’s statistics published in March 2020, more than 530 million children suffer from dental caries of primary teeth and approximately 3.5 billion people are affected by oral diseases. Moreover, oral cancer is the third most common type of cancer in the Asia-Pacific. Thus, a growing number of dental disorders are fueling the demand for dental imaging systems including dental X-rays for diagnosis and treatment for dental disorders. Major players in the dental X-ray equipment market are Danaher Corporation, Cefla S.C., Fujifilm, Bio-Medicare, Panoramic Corporation, Midmark Corporation, Air Techniques Inc., The Yoshida Dental Mfg. Co. Ltd., LED Medical Diagnostics Inc., and Vatech Co. Ltd. Low healthcare access in developing countries limits the growth of the dental X-ray equipment market. The lack of healthcare resources such as money, infrastructure, and knowledgeable healthcare providers makes it difficult for people to access healthcare services. Healthcare access is comparatively poor in developing countries, compared to developed nations. For instance, according to the Journal of Global Oral Health, in Uganda, in 97 out of 112 districts surveyed, 15% of the population had no public clinic and were located in the poorest regions of Uganda. Moreover, among 40 districts with 90% of the rural population, 20% had none and 55% only had one dental clinic. The low healthcare access impacts the demand in developing nations thereby hampering the demand for the dental X-ray equipment market. The launch of handheld and portable X-ray systems is gaining significant popularity in the dental X-ray equipment market. The companies operating in the industry are majorly focusing on developing advanced equipment to meet the healthcare professional requirements. For instance, in 2021, Carestream Dental has launched the CS 2400P, a portable x-ray generator. The best features are a battery-free recharging system, the CS 2400P is designed to take high-quality diagnostic images. the system could go from completely discharged to ready-to-go in less than 3 minutes and deliver multiple shots before require to be recharged, which reportedly only takes seconds. The system also utilizes a short exposure time to decrease the risk of motion and to develop sharpness. In April 2022, Envista Holdings Corporation, a US-based dental equipment and supplies manufacturing company acquired Carestream Dental’s Intraoral scanner business. The acquisition would further enable company’s purpose of partnering with dental professionals to improve patient’s lives. Carestream dental is a India-based digital imaging service provider for dental applications. Asia-Pacific was the largest region in the dental X-ray equipment market in 2022. Western Europe was the second-largest region in the dental X-ray equipment market report. The regions covered in the dental X-ray equipment analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the dental X-ray equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The dental X-ray equipment market consists of sales of Intraoral X-ray Sensors, Digital Panoramic X-rays, Dental Cone Beam Systems, and Phosphor Plate X-ray Systems for taking dental X-rays. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The dental X-ray equipment market research report is one of a series of new reports from The Business Research Company that provides dental X-ray equipment market statistics, including dental X-ray equipment industry global market size, regional shares, competitors with a dental X-ray equipment market share, detailed dental X-ray equipment market segments, market trends and opportunities, and any further data you may need to thrive in the dental X-ray equipment industry. This dental X-ray equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dental diagnostic imaging devices and equipment create a visual representation of the inner tooth body for clinical analysis. These devices are used for better analysis of dental problems such as tooth decay, tooth erosion, and gum disease. The main methods in dental diagnostic imaging devices and equipment market are intraoral imaging and extraoral imaging. Intraoral imaging refers to the intraoral cameras that are used to provide accurate images of the teeth. The various technologies are X-Ray Systems, dental cone beam computed tomography, magnetic resonance imaging, and others. These are used in hospitals, dental clinics, forensic labs, and others. The global dental diagnostic imaging devices and equipment market is segmented - 1) By Method: Intraoral Imaging, Extraoral Imaging 2) By End Users: Hospitals, Dental Clinics, Forensic Labs, Other End Users 3) By Technology: X-Ray Systems, Dental Cone Beam Computed Tomography, Magnetic Resonance Imaging, Other Technologies The global dental diagnostic imaging devices and equipment market size will grow from $2.41 billion in 2022 to $2.72 billion in 2023 at a compound annual growth rate (CAGR) of 13.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global dental diagnostic imaging devices and equipment is expected to grow to $4.36 billion in 2027 at a CAGR of 12.5%. The growing awareness of dental health care has led to demand for a proper healthcare system with upgraded devices. The dental diagnostic imaging devices and equipment market help to meet the oral healthcare demands of people and will drive market growth. These imaging devices help to reduce shorten the recovery time for a patient and also result in less pain when compared to earlier methods of diagnosing dental problems. According to Adults Oral Health & Well-being Survey, 85% of Americans believe that oral health is extremely important among which only 15% were satisfied with their current oral health. This indicates that people look for better dental care now and are aware of the importance of oral healthcare which will drive the dental diagnostic imaging devices and equipment market growth. Major players in the dental diagnostic imaging devices and equipment market are Carestream Health Inc., Fujifilm Holdings Corporation, Hitachi Medical Corporation, Siemens Healthcare, GE Healthcare, Philips Healthcare, Hologic Inc., Canon, Shimadzu Corporation, and Toshiba Medical Systems Corporation. The lack of consumer awareness on the available dental diagnostic imaging devices in many developing economies is restraining the dental diagnostic imaging devices and equipment market growth. People in many developing countries tend to neglect dental problems due to a lack of awareness. This attitude affects the health and also the growth of the dental diagnostic imaging device market as the use and procurement of these devices are affected negatively. For example, WHO has provided technical and financial support to the Ministry of Public Health and Education is conducting a series of workshops and campaigns on oral health for schoolteachers in Kabul city. These workshops aim to raise awareness of oral health and prevention of negligence towards dental problems in the dental diagnostic imaging devices and equipment market. The need for precise diagnostic tools has given rise to innovation in dental imaging technology such as cone beam computed tomography (CBCT) and magnetic resonance imaging and others. These new techniques have helped in a better examination of complex facial structures and early diagnosis of dental diseases. For example, the All-India Institute of Medical Sciences (AIIMS) started the use of a Cone Beam CT (CBCT) scan facility that would help dental surgeons in increasing the efficiency of their dental surgeries. These devices provide a 3D image of the patient's jaw to get precise knowledge of the problem before the surgery is performed and help in safe and better treatment outcomes. Various government reforms and organizations are currently focusing on dental care safety and aim to reduce oral health care problems. For example, FDA's Center for Devices and radiological health is responsible for regulating firms that manufacture, repackage or import medical devices sold in the United States. Also, CDRH regulates medical devices such as radiation-emitting electronic products such as lasers, x-ray systems, and ultrasound equipment. Asia-Pacific was the largest region in the global dental diagnostic imaging devices and equipment market in 2022. Western Europe was the second-largest region in dental diagnostic imaging devices and equipment market report. The regions covered in the dental diagnostic imaging devices and equipment industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the dental diagnostic imaging devices market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. Dental diagnostic imaging devices and equipment consists of sales of Extraoral Imaging Systems, (Panoramic Systems, Panoramic & Cephalometric Systems, 3d CBCT Systems) And Intraoral Imaging Systems (Intraoral X-Ray Systems, Intraoral Sensors, and Intraoral PSP Systems) for dental diagnostic imaging that are used for diagnosis of dental diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The dental diagnostic imaging devices and equipment market research report is one of a series of new reports from The Business Research Company that provides dental diagnostic imaging devices and equipment market statistics, including dental diagnostic imaging devices and equipment industry global market size, regional shares, competitors with a dental diagnostic imaging devices and equipment market share, detailed dental diagnostic imaging devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the dental diagnostic imaging devices and equipment industry. This dental diagnostic imaging devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dental equipment and supplies consist of tools, instruments, and supplies used by dentists, dental hygienists, and laboratories to provide dental treatment. The main types in the dental equipment and supplies are therapeutic dental equipment, general dental devices, and equipment, dental diagnostic imaging devices, and equipment, dental surgical devices, and equipment. Therapeutic dental equipment is used for the treatment of dental diseases. The type of expenditure used is public, private. The products used are instruments/equipment, disposables. The various end-users involved are hospitals and clinics, diagnostic laboratories, and others. The global dental equipment and supplies market is segmented - 1) By Type: Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables The global dental equipment and supplies market size grew from $22.36 billion in 2022 to $24.99 billion in 2023 at a compound annual growth rate (CAGR) of 11.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global dental equipment and supplies is expected to grow to $38.41 billion in 2027 at a CAGR of 11.3%. The growth in the older population is expected to drive the dental equipment and supplies market. The older population is prone to a number of dental problems and extensive tooth loss, which increases exponentially with age, thus generating demand for dental equipment and supplies, used for diagnostic, therapeutic and surgical purposes. For instance, the United Nations estimates that the population of older adults (aged 65 years or above) globally to increase from 703 million in 2019 to 1.5 billion by 2050. Additionally, in Japan, the percentage of seniors is expected to grow from 28% in 2019 to 38% in 2050. Hence, the increasing older population is expected to drive the growth of the dental equipment and supplies market during the forecast period. Major companies in the dental equipment and supplies market include Dentsply Sirona, Danaher, Carestream Health, 3M, Straumann. The dental industry is continuously incorporating advanced technologies for the manufacturing of dentures. Digital dentures deal with workflow involved in the fabrication of dentures which are prosthetic devices meant to replace missing teeth. This process utilizes software modules such as computer-aided design and computer-aided manufacturing (CAD/CAM) and materials to create precision-fitted dentures in short durations. The inclusion of this concept allows dental technicians to fabricate prostheses using material discs with quicker design time and better fit. Companies that offer digital dentures include AvaDent, DENTCA, Dentsply Sirona, Amann Girrbach. Asia-Pacific was the largest region in the global dental equipment and supplies market in 2022. Western Europe was the second-largest region in the global dental equipment and supplies market share. Africa. was the smallest region in the global dental equipment and supplies industry analysis. The regions covered in the dental equipment and supplies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the dental equipment and supplies market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The dental equipment and supplies market consists of sales of dental radiology equipment, dental surgical navigation systems, CAD/CAM equipment, dental chairs, and other dental devices that are used for treatment of dental disorders. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The dental equipment and supplies market research report is one of a series of new reports from The Business Research Company that provides dental equipment and supplies global market statistics, including dental equipment and supplies industry global market size, regional shares, competitors with a dental equipment and supplies global market share, detailed dental equipment and supplies market segments, market trends and opportunities, and any further data you may need to thrive in the dental equipment and supplies industry. This dental equipment and supplies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Dental therapy is the process of restoring the health of the teeth and gums. Therapeutic dental equipment is used for the treatment of dental diseases. The main products in the therapeutic dental equipment market are soft tissue lasers and all tissue lasers. Soft tissue dental equipment is used in the treatment of dental issues. Soft tissue lasers are used in ablating and removing aphthous ulcers, troughing, crown lengthening, soft tissue incisions, and removing soft tissue lesions. These are used in various therapeutic areas such as restorative dentistry, orthodontics, endodontics, and other therapeutic areas. These are used by hospitals, clinics, and dental laboratories. The global therapeutic dental equipment market is segmented - 1) By Product: Soft tissue Lasers, All tissue Lasers 2) By End user: Hospitals, Clinics, Dental laboratories 3) By Therapeutic Area: Restorative dentistry, Orthodontics, Endodontics, Other therapeutic areas The global therapeutic dental equipment market size will grow from $2.27 billion in 2022 to $2.58 billion in 2023 at a compound annual growth rate (CAGR) of 13.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global therapeutic dental equipment is expected to grow to $4.22 billion in 2027 at a CAGR of 13.1%. The changing lifestyles and unhealthy habits of people have increased the instances of oral disease & has increased the demand for dental and oral care. The major lifestyle changes that have stimulated periodontal diseases include smoking, inadequate oral hygiene, and unawareness about dental health. Diabetes is also one of the major reasons for oral diseases. With the increasing diabetic population, which is estimated to rise by 154% (to 642 million in 2040), the need for periodontal care is expected to rise. These lifestyle changes along with rising diabetes prevalence are expected to increase the demand for dental care and surgeries thereby driving the therapeutic dental equipment market growth. Major players in the therapeutic dental equipment market are AMD LASERS LLC., BIOLASE Technology Inc., Danaher Corporation, Dentsply Sirona, Planmeca Group, A-dec Inc., 3M Company, Midmark Corporation, A.R.C. Laser, Carestream Health Inc., and The Yoshida Dental Mfg. Co. Ltd. The painless procedure using dental lasers has complications that affect the tooth and the surrounding dental region. Tooth surface, dental pulp, subcutaneous and submucosal layers are some of the regions prone to adverse effects during the use of dental lasers. Necrosis of the pulp, bone resorption, hypo/hyperpigmentation, scarring among others is the complications associated with dental lasers. In addition to this, the micro-hardness of the tooth walls is also affected, resulting in surface cracks of the tooth. Due to these effects, the growth of the therapeutic dental equipment market is expected to be restrained in the future. There have been continuous technological advancements in dental lasers that are resulting in a positive impact on the growth of the dental laser industry. For instance, in 2020, Summus Medical Laser, the leading provider of high-powered laser therapy products, launched the horizon dental laser system, the first Class IV therapy laser system designed specifically for the dental industry. The development of such new technologically advanced devices will augment industry growth. In the USA, manufacturers of laser devices in the medical device industry must comply with the Title 21 Code of Federal Regulations (CFR). As per the Title 21 Code of Federal Regulation, the performance standard and specific purpose of the laser product must also be mentioned along with other records on calibration that are provided to the customers. Daheng Group Inc. recalled its Diode Laser Therapy System and Dental Laser Therapy System as it failed to comply with 21 CFR 1040.11 and did not provide calibration procedures to purchasers. In the UK, institutions employing laser for dental surgeries must register with the Care Quality Commission, and the National Minimum Standards and Regulations for Independent Health Care 2002 state all the standards (C1 to C32) that are a mandate to all hospitals and dental clinics that use lasers. According to the core standards, the operators must have a patient guide explaining the benefits and risks of laser, a statement of treatment policy, management and personnel, a complaints procedure, premises, facilities and equipment management, risk management procedure, and research strategy in place. Asia-Pacific was the largest region in the global therapeutic dental equipment market in 2022. Western Europe was the second-largest region in the therapeutic dental equipment market report. The regions covered in the therapeutic dental equipment industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in therapeutic dental equipment are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The therapeutic dental equipment market consists of sales of dental lasers, soft-tissue laser systems, diode laser systems, CO2 laser systems, YAG laser systems, and all-tissue (hard/soft) laser systems that are used for dental therapies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The therapeutic dental equipment market research report is one of a series of new reports from The Business Research Company that provides therapeutic dental equipment market statistics, including therapeutic dental equipment industry global market size, regional shares, competitors with a therapeutic dental equipment market share, detailed therapeutic dental equipment market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic dental equipment industry. This therapeutic dental equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Biologics are medications made from organic materials that can be used to treat a wide range of illnesses, and they are frequently used to treat immune-related illnesses such Crohn's disease, psoriasis, ankylosing spondylitis, and rheumatoid arthritis. The interesting aspect is that biologics are separated from various natural sources, whether they be carbohydrates, proteins, nucleic acids, or a complex mixture of these materials. The main types of biologics are monoclonal antibodies (MAbs), therapeutic proteins, and vaccines. Monoclonal antibodies, or mAbs, are created in a laboratory to combat a specific infection. The various route of administration includes oral, parenteral, and others that are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others. The global biologics market is segmented - 1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribtuion Channels 3) By Route Of Administration: Oral, Parenteral, Other Route Of Administration 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs Subsegments Covered: Anti-Cancer MAbS, Immunological MAbS, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MABS, Cardiovascular And Cerebrovascular MAbS, Other Monoclonal Antibodies (MAbs), Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Other Therapeutic Proteins, Anti-Infective Vaccines, Autoimmunity Vaccines, Other Vaccines The global biologics market size is expected to grow from $382.04 billion in 2022 to $416.65 billion in 2023 at a compound annual growth rate (CAGR) of 9.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, and affecting many markets across the globe. The market size of global biologics market is expected to reach $599.62 billion in 2027 at a CAGR of 9.5%. Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. For example, Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early drug discovery that have been operational within hours, whereas traditional models would have taken weeks to conduct simulations. The Open Innovation Drug Discovery program is another initiative by Lilly to enhance the research and development of biologics. Such technological advances are likely to reduce costs and expedite the development phase of biologics, allowing companies to launch their products early. Major companies in the biologics market include AbbVie, Johnson & Johnson, Amgen, Sanofi S.A, F. Hoffmann-La Roche Ltd., GlaxosmithKline, Novartis AG, Pfizer Inc., Teva Pharmaceuticals and CSL. The early generation of biologics is losing its patent protection and is expected to face greater competition going forward from the entry of biosimilars into the market. Biosimilars are pharmaceuticals that are developed to have similar properties to a biological drug that has already been approved. Demand for biosimilars is being fueled by governments around the world trying to reduce healthcare costs. In India, a new biosimilar policy called the ‘Guidelines on Similar Biologics’ prepared by the Central Drugs Standard Control Organization (CSDCO) is expected to give a major boost to the Indian biosimilars industry. In the EU, a pathway for approving biosimilar medicines has existed since 2003. These less expensive alternatives increase the competitiveness of the biologics market putting downward pressure on pricing and market value growth. The US Food and Drug Administration (FDA) has revised its regulations to eliminate outdated biologics requirements, thus allowing drug manufacturers to employ new manufacturing technologies and testing capabilities. Standard preparations (standard solutions containing a precisely known concentration of an element), which help to ensure the safety, purity, and potency of biologics can now be obtained from sources other than FDA’s Center for Biologics Evaluation and Research (CBER) or can be developed internally by the biologics license applicant. The FDA has also removed a rule (Section 610.21 of FDA code) that specifies minimal potency limits to be met for certain antibodies and antigens. In addition, FDA is also updating regulations (Section 610.53 of FDA code) regarding storage periods and storage conditions for biologics. These amendments in regulations are expected to increase regulatory flexibility by allowing the pharmaceutical industry and the FDA to incorporate current scientific technologies in the manufacture of licensed biological products. North America was the largest region in the biologics market share in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the global biologics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the biologics market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The biologics market consists of sales of Tumor necrosis factor inhibitors, Interleukin inhibitors, B-cells inhibitors, and T-cells inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The biologics market research report is one of a series of new reports from The Business Research Company that provides biologics market statistics, including biologics industry global market size, regional shares, competitors with a biologics market share, detailed biologics market segments, market trends, and opportunities, and any further data you may need to thrive in the biologics industry. This biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Biosimilars are medications made from living things, though they can be made in a variety of ways and with slightly different materials. Due to the intricacy and high cost of their creation, as well as their molecular size and structure, biosimilars are fundamentally distinct from generic drugs. The main types of biosimilars are human growth hormone, erythropoietin, monoclonal antibodies, insulin, interferon, granulocyte-colony stimulating factor, and others. Erythropoietin is a hormone produced by the kidneys to stimulate the production and maintenance of vital red blood cells. The various products include recombinant non-glycosylated proteins and recombinant glycosylated proteins that are used for the treatment of oncology, chronic and autoimmune diseases, growth hormone deficiency, infectious diseases, and others. The global biosimilars market is segmented - 1) By Product: Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins 2) By Types: Human Growth Hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Other Types 3) By Application: Oncology, Chronic and Autoimmune Diseases, Growth Hormone Deficiency, Infectious Diseases, Other Applications The biosimilars market size grew from $19.1 billion in 2022 to $23.28 billion in 2023 at a compound annual growth rate (CAGR) of 21.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of biosimilars is expected to grow from $47.82 billion in 2027 at a CAGR of 19.7%. The rising prevalence of chronic diseases such as arthritis, asthma, and cancer is expected to be a major driver of the biosimilars market. Long working hours, limited physical activity, and unhealthy eating and drinking habits contribute to the prevalence of chronic diseases and biosimilars are increasingly used to treat these chronic diseases. Biosimilars activate the immune system response against cancer cells thus helping the immune system to eliminate the cancer cells from the body. According to a United Nations article, by 2030 the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic disease is expected to reach about 60%. Therefore, the rise in the prevalence of chronic diseases is projected to propel the demand for biosimilars, thus driving the biosimilars market. Major players in the biosimilars market are Pfizer, Amgen, Biocon, Celltrion, Dr. Reddy's Laboratories, Boehringer Ingelheim, Elli Lilly and Company, Mylan N.V., Sanofi, STADA Arzneimittel, Sandoz International, Samsung Bioepis, Teva Pharmaceuticals, Apotex, AMEGA Biotech S.A., Bioton S.A., Innovent Biologics International, Allergan PLC., BioXpress Therapeutics, 3SBio, Intas Biopharmaceuticals, Lupin Merck, Novartis, Ratiopharm, Wockhardt, Zydus Cadila, Allergan PLC., Hospira International., Actavis International., Johnson & Johnson and Roche. The lack of awareness about biosimilars among primary care physicians (PCPs) and specialists limits the growth of the biosimilars market. Biosimilars are manufactured from cell lines and offer the same effectiveness as biologics. However, a lack of familiarity with biosimilars reduces the likelihood of prescribing the drugs to patients which affects the demand for new biosimilars in the market. For instance, according to the PwC’s Health Research Institute, out of 442 clinicians surveyed 55% of clinicians were unfamiliar with biosimilars and 35% were reluctant to prescribe them due to concerns including the safety of the follow-on biologic. Thus, the lack of awareness about biosimilars among primary care physicians (PCPs) and specialists restricts the growth of the biosimilars market. Production of new insulin biosimilars is trending in the biosimilars market. The key players operating in the biosimilars market are investing in creating a biosimilar of insulin. This is also promoting competition among various biosimilar manufacturers. For instance, in August 2020, Biocon Biologics India Ltd., an India-based fully integrated global biosimilars organization, in partnership with Mylan, a US-based biosimilar company, has launched Semglee, insulin glargine injection in the U.S. to aid in lowering blood sugar levels in adults with type 2 diabetes and children with type 1 diabetes. North America was the largest region in the global biosimilars market in 2022. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biosimilars market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the biosimilars market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The biosimilars market consists of sales of binocrit, epoetin alfa hexal, and abseamed. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The biosimilars market research report is one of a series of new reports from The Business Research Company that provides biosimilars market statistics, including biosimilars industry global market size, regional shares, competitors with a biosimilars market share, detailed biosimilars market segments, market trends, and opportunities, and any further data you may need to thrive in the biosimilars industry. This biosimilars market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.